Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edelgard Lindhoff-Last

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Thrombosis and Haemostasis|July 29, 2024
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance ReviewTruman J Milling, Anna Voronov, Dirk S Schmidt, et al.
Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet activation markers in patients with venous thromboembolism without predisposing factorsFrank Gerdsen, Martin Weber, Florian Langer, et al.
Platelets|August 25, 2006
Response to aspirin and clopidogrel monitored with different platelet function methodsHelen Mani, Birgit Linnemann, Beate Luxembourg, et al.
Thrombosis Research|October 11, 2011
Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative diseaseBirgit Linnemann, Christiane Kraft, Martin Roskos, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2013
The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulationWaltraud Pfeilschifter, Sebastian Luger, Robert Brunkhorst, et al.
Annals of Hematology|January 6, 2010
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2YBirgit Linnemann, Jan Schwonberg, Andreas R Rechner, et al.
British Journal of Haematology|August 30, 2002
Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparinEdelgard Lindhoff-Last, Roumen Nakov, Frank Misselwitz, et al.
The New England Journal of Medicine|October 4, 2023
Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 DisorderEdelgard Lindhoff-Last, Linda Schönborn, Carlo Zaninetti, et al.
Contact Dermatitis|March 16, 2017
Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responsesMarc Schindewolf, Andreas Recke, Detlef Zillikens, et al.
Atherosclerosis|February 16, 2010
Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive diseaseBirgit Linnemann, Jan Schwonberg, Stefan W Toennes, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Thrombosis and Haemostasis|July 29, 2024
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance ReviewTruman J Milling, Anna Voronov, Dirk S Schmidt, et al.
Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet activation markers in patients with venous thromboembolism without predisposing factorsFrank Gerdsen, Martin Weber, Florian Langer, et al.
Platelets|August 25, 2006
Response to aspirin and clopidogrel monitored with different platelet function methodsHelen Mani, Birgit Linnemann, Beate Luxembourg, et al.
Thrombosis Research|October 11, 2011
Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative diseaseBirgit Linnemann, Christiane Kraft, Martin Roskos, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2013
The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulationWaltraud Pfeilschifter, Sebastian Luger, Robert Brunkhorst, et al.
Annals of Hematology|January 6, 2010
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2YBirgit Linnemann, Jan Schwonberg, Andreas R Rechner, et al.
British Journal of Haematology|August 30, 2002
Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparinEdelgard Lindhoff-Last, Roumen Nakov, Frank Misselwitz, et al.
The New England Journal of Medicine|October 4, 2023
Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 DisorderEdelgard Lindhoff-Last, Linda Schönborn, Carlo Zaninetti, et al.
Contact Dermatitis|March 16, 2017
Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responsesMarc Schindewolf, Andreas Recke, Detlef Zillikens, et al.
Atherosclerosis|February 16, 2010
Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive diseaseBirgit Linnemann, Jan Schwonberg, Stefan W Toennes, et al.
Pageof 12